Psoriasis is a chronic, immune-mediated inflammatory skin condition characterized by the rapid overproduction of skin cells, leading to thick, scaly plaques that can be itchy, painful, or disfiguring. Understanding the Condition While Psoriasis is primarily recognized as a skin disease, it is fundamentally a systemic condition. It occurs when the immune system becomes overactive, triggering skin cells to multiply up to ten times faster than normal. These cells build up on the skin's surface, creating the hallmark red patches covered with silvery scales. Because it is systemic, Psoriasis can affect more than just the skin; many patients also experience inflammation in the joints, known as psoriatic arthritis, and are at a higher risk for cardiovascular issues and metabolic syndrome. Subtypes and Demographics There are several distinct forms of the disease, including: Plaque Psoriasis: The most common form, presenting as raised, red patches with silvery scale. Guttate Psoriasis: Small, drop-shaped lesions often triggered by a streptococcal infection. Inverse Psoriasis: Smooth, red patches in skin folds like the armpits or groin. Pustular and Erythrodermic Psoriasis: Rarer, more severe forms requiring urgent medical attention. Psoriasis affects approximately 2-3% of the global population, with no significant difference in prevalence between genders. It can manifest at any age, though it most commonly appears in two peaks: between 15–30 years and 50–60 years. While it occurs worldwide, prevalence rates are often higher in populations further from the equator, likely due to reduced sun exposure. Key Differentiators Unlike simple dermatitis or eczema, Psoriasis is defined by its distinct "silvery scale" and the specific histological finding of hyperproliferation of keratinocytes. It is a lifelong condition with a relapsing-remitting course, meaning symptoms may flare up due to triggers like stress, injury, or infection, and then subside for periods of time. Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a dermatologist or qualified healthcare provider regarding your specific medical condition. References National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH Genetic and Rare Diseases Information Center (GARD) National Psoriasis Foundation (NPF)

Short answer · Medically reviewed summary · Last updated: 2026-04-06

Psoriasis is a chronic, immune-mediated inflammatory skin condition characterized by the rapid overproduction of skin cells, leading to thick, scaly plaques that can be itchy, painful, or disfiguring. Understanding the Condition While Psoriasis is primarily recognized as a skin disease, it is fundamentally a systemic condition. It occurs when the immune system becomes overactive, triggering skin cells to multiply up to ten times faster than normal.

What is Psoriasis

Name: What is Psoriasis
Creator: DiseaseMaps Editorial Team
Published: 2015-06-11UTC09:16:50.0000000

What is Psoriasis? Plain-language, medically reviewed definition plus the lived reality told by patients.

Understanding the Condition

While Psoriasis is primarily recognized as a skin disease, it is fundamentally a systemic condition. It occurs when the immune system becomes overactive, triggering skin cells to multiply up to ten times faster than normal. These cells build up on the skin's surface, creating the hallmark red patches covered with silvery scales. Because it is systemic, Psoriasis can affect more than just the skin; many patients also experience inflammation in the joints, known as psoriatic arthritis, and are at a higher risk for cardiovascular issues and metabolic syndrome.

Subtypes and Demographics

There are several distinct forms of the disease, including:

Plaque Psoriasis: The most common form, presenting as raised, red patches with silvery scale.

Guttate Psoriasis: Small, drop-shaped lesions often triggered by a streptococcal infection.

Inverse Psoriasis: Smooth, red patches in skin folds like the armpits or groin.

Pustular and Erythrodermic Psoriasis: Rarer, more severe forms requiring urgent medical attention.

Psoriasis affects approximately 2-3% of the global population, with no significant difference in prevalence between genders. It can manifest at any age, though it most commonly appears in two peaks: between 15–30 years and 50–60 years. While it occurs worldwide, prevalence rates are often higher in populations further from the equator, likely due to reduced sun exposure.

Key Differentiators

Unlike simple dermatitis or eczema, Psoriasis is defined by its distinct "silvery scale" and the specific histological finding of hyperproliferation of keratinocytes. It is a lifelong condition with a relapsing-remitting course, meaning symptoms may flare up due to triggers like stress, injury, or infection, and then subside for periods of time.

Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a dermatologist or qualified healthcare provider regarding your specific medical condition.

References

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH Genetic and Rare Diseases Information Center (GARD)

National Psoriasis Foundation (NPF)

Author: DiseaseMaps Editorial Team

Reviewed against authoritative medical sources (NIH GARD, Orphanet, OMIM)

Last updated: 2026-04-06

Sources cited: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · NIH Genetic and Rare Diseases Information Center (GARD) · National Psoriasis Foundation (NPF)

Medical disclaimer: This information does not substitute professional medical advice. Always consult your doctor before making health decisions.

Source: DiseaseMaps.org

1 answer